• OPEN AN ACCOUNT
Indian Indices
Sensex
77,264.51 330.92
( 0.43%)
Global Indices
Nasdaq
53,583.69 98.81
(0.18%)
Dow Jones
7,750.97 54.27
(0.71%)
Hang Seng
66,369.62 237.64
(0.36%)
Nikkei 225
10,795.58 -82.54
(-0.76%)
Forex
USD-INR
95.26 -0.05
(-0.05%)
EUR-INR
111.07 -0.11
(-0.10%)
GBP-INR
129.70 -0.28
(-0.21%)
JPY-INR
0.60 0.00
(0.01%)

EQUITY - MARKET SCREENER

Curis Lifesciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
94348
INE1BZN01016
58.5748291
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CURIS
14.58
101.02
EPS(TTM)
Face Value()
Div & Yield %
8.57
10
0
 

Sarvamangal Mercantile Co. reports standalone net loss of Rs 0.30 crore in the March 2026 quarter
May 30,2026
Net Loss of Sarvamangal Mercantile Co. reported to Rs 0.30 crore in the quarter ended March 2026 as against net loss of Rs 0.65 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.

For the full year,net profit declined 76.97% to Rs 0.41 crore in the year ended March 2026 as against Rs 1.78 crore during the previous year ended March 2025. Sales reported to Rs 0.06 crore in the year ended March 2026. There were no Sales reported during the previous year ended March 2025.